Russell Investments Group, Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 315,373 shares of ARWR stock, worth $6.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

315,373

Previous 264,783 19.11%

Holding current value

$6.42 Million

Previous $6.88 Million 11.28%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.36 - $29.54 $979,422 - $1.49 Million	50,590 Added 19.11%	315,373 $6.11 Million
Q2 2024 Aug 08, 2024	BUY	$21.87 - $28.24 $484,354 - $625,431	22,147 Added 9.13%	264,783 $6.88 Million
Q1 2024 May 08, 2024	SELL	$27.21 - $39.48 $140,975 - $204,545	-5,181 Reduced 2.09%	242,636 $6.94 Million
Q4 2023 Feb 05, 2024	BUY	$21.2 - $31.03 $499,005 - $730,384	23,538 Added 10.49%	247,817 $7.58 Million
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $210,071 - $289,289	8,018 Added 3.71%	224,279 $6.03 Million
Q2 2023 Aug 10, 2023	SELL	$25.16 - $41.38 $292,786 - $481,539	-11,637 Reduced 5.11%	216,261 $7.71 Million
Q1 2023 May 09, 2023	SELL	$23.68 - $38.51 $490,436 - $797,580	-20,711 Reduced 8.33%	227,898 $5.79 Million
Q4 2022 Feb 08, 2023	BUY	$28.0 - $40.56 $460,992 - $667,779	16,464 Added 7.09%	248,609 $10.1 Million
Q3 2022 Nov 04, 2022	BUY	$29.63 - $48.31 $452,687 - $738,080	15,278 Added 7.04%	232,145 $7.67 Million
Q2 2022 Jul 29, 2022	SELL	$27.79 - $50.61 $890,391 - $1.62 Million	-32,040 Reduced 12.87%	216,867 $7.63 Million
Q1 2022 May 05, 2022	BUY	$39.62 - $69.97 $1.47 Million - $2.59 Million	36,984 Added 17.45%	248,907 $11.4 Million
Q4 2021 Jan 21, 2022	BUY	$58.09 - $82.51 $1.71 Million - $2.42 Million	29,385 Added 16.1%	211,923 $14 Million
Q3 2021 Nov 08, 2021	BUY	$58.38 - $84.96 $615,733 - $896,073	10,547 Added 6.13%	182,538 $11.4 Million
Q2 2021 Aug 04, 2021	BUY	$62.15 - $90.32 $5.12 Million - $7.44 Million	82,349 Added 91.86%	171,991 $14.2 Million
Q1 2021 May 10, 2021	SELL	$61.35 - $90.47 $1.07 Million - $1.58 Million	-17,416 Reduced 16.27%	89,642 $5.94 Million
Q4 2020 Feb 08, 2021	BUY	$43.82 - $85.37 $1.94 Million - $3.78 Million	44,228 Added 70.39%	107,058 $8.22 Million
Q2 2020 Aug 05, 2020	BUY	$26.12 - $43.27 $975,111 - $1.62 Million	37,332 Added 146.41%	62,830 $2.71 Million
Q1 2020 May 06, 2020	SELL	$20.56 - $63.12 $407,437 - $1.25 Million	-19,817 Reduced 43.73%	25,498 $732,000
Q4 2019 Jan 29, 2020	SELL	$28.14 - $73.01 $861,084 - $2.23 Million	-30,600 Reduced 40.31%	45,315 $2.88 Million
Q3 2019 Nov 01, 2019	BUY	$26.26 - $34.86 $95,638 - $126,960	3,642 Added 5.04%	75,915 $2.14 Million
Q2 2019 Aug 09, 2019	BUY	$17.43 - $28.82 $343,702 - $568,301	19,719 Added 37.52%	72,273 $1.92 Million
Q1 2019 May 13, 2019	BUY	$12.05 - $20.18 $633,275 - $1.06 Million	52,554 New	52,554 $964,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.16B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History